Ribomic (TSE:4591) Total Stockholders Equity: 円2,841.12 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4591 Ribomic Inc TSE:4591
26 GF Score
Price 円73.00
! 3 Warning Signs
View Full Analysis

What is Ribomic Total Stockholders Equity?

Ribomic TSE:4591 +4.29% 26 Total Stockholders Equity is 円2,841.12 Mil as of Mar. 2026. GuruFocus rates TSE:4591 with a GF Score™ of 26/100. The stock has 3 warning signs investors should review.

Ribomic's Total Stockholders Equity for the quarter that ended in Mar. 2026 was 円2,841.12 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Ribomic's Book Value per Share for the quarter that ended in Mar. 2026 was 円52.31. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Ribomic's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.00.

Ribomic  (TSE:4591) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Ribomic's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(2841.123-0)/54.309
=52.31

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Ribomic's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 2841.123
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ribomic Total Stockholders Equity Related Terms

Ribomic Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Ribomic's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ribomic Total Stockholders Equity Chart

Ribomic Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,693.95 4,384.35 3,391.45 3,043.63 2,841.12

Ribomic Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,391.45 3,286.07 3,043.63 3,236.24 2,841.12
TSE:4591
26GF Score
Ribomic Inc TSE:4591
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of 円2,841.12 Mil mean?
Ribomic (TSE:4591) has a Total Stockholders Equity of 円2,841.12 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Ribomic and its competitors.
Is Ribomic's Total Stockholders Equity too high?
Ribomic's current Total Stockholders Equity is 円2,841.12 Mil. Overall, Ribomic has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Ribomic's Total Stockholders Equity compare to VRTX and REGN?
Ribomic's Total Stockholders Equity of 円2,841.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Ribomic and its competitors. Ribomic's current Total Stockholders Equity is 円2,841.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ribomic stock overvalued right now?
Ribomic (TSE:4591) has a current Total Stockholders Equity of 円2,841.12 Mil. The current Total Stockholders Equity is 円2,841.12 Mil. Ribomic's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Ribomic (TSE:4591), the current Total Stockholders Equity is 円2,841.12 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ribomic Business Description

Address 3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
26GF Score

Get the complete analysis for TSE:4591

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円73.00
Price